scholarly journals A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma

2018 ◽  
Vol 29 (4) ◽  
pp. 979-984 ◽  
Author(s):  
C. Fushimi ◽  
Y. Tada ◽  
H. Takahashi ◽  
T. Nagao ◽  
H. Ojiri ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Androgen Receptor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Salivary Gland Carcinoma ◽  
Combined Androgen Blockade ◽  
Prospective Phase ◽  
Gland Carcinoma ◽  
Androgen Blockade

Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients

Cancer ◽  
1991 ◽  
Vol 68 (9) ◽  
pp. 1874-1877 ◽  
Author(s):  
Lisa Licitra ◽  
Silvana Marchini ◽  
Silvia Spinazzè ◽  
Anna Rossi ◽  
Andrea Rocca ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Salivary Gland Carcinoma ◽  
Gland Carcinoma

PO-164: PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic salivary gland carcinoma

2015 ◽  
Vol 114 ◽  
pp. 76-77
Author(s):  
D. Cupissol ◽  
C. Even ◽  
J. Fayette ◽  
F. Rolland ◽  
B. Laguerre ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Salivary Gland Carcinoma ◽  
Gland Carcinoma

PACSA: Phase II study of pazopanib in patients with progressive recurrent or metastatic (R/M) salivary gland carcinoma (SGC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 6086-6086 ◽  
Author(s):  
Joel Guigay ◽  
Jerome Fayette ◽  
Caroline Even ◽  
Didier Cupissol ◽  
Frederic Rolland ◽  
...  
Keyword(s):  
Salivary Gland ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Salivary Gland Carcinoma ◽  
Gland Carcinoma
Sign in / Sign up

Export Citation Format

Share Document